Analysts Downgrade Accenture Forecasts Following Q4 Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 26 2025
0mins
Source: Benzinga
Earnings Report: Accenture plc reported fourth-quarter 2025 earnings of $3.03 per share and sales of $17.60 billion, both exceeding analyst expectations.
Future Projections: The company forecasts fiscal 2026 sales between $71.07 billion and $73.16 billion, with GAAP EPS expected to be between $13.19 and $13.57, and plans to return at least $9.3 billion to shareholders.
Stock Performance: Following the earnings announcement, Accenture shares rose by 3% to $239.54.
Analyst Ratings: Several analysts maintained their ratings on Accenture while adjusting price targets downward, with the new targets ranging from $285 to $330.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ACN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ACN
Wall Street analysts forecast ACN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACN is 295.67 USD with a low forecast of 251.00 USD and a high forecast of 330.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
16 Analyst Rating
10 Buy
6 Hold
0 Sell
Moderate Buy
Current: 261.220
Low
251.00
Averages
295.67
High
330.00
Current: 261.220
Low
251.00
Averages
295.67
High
330.00
About ACN
Accenture plc is a global professional services company. It is engaged in providing a range of services and solutions across strategy and consulting, technology, operations, Industry X and Song. Its services include application services, artificial intelligence, automation, business process outsourcing, business strategy, change management, cloud, customer experience, data and analytics, ecosystem partners, finance consulting, Industry X, infrastructure, marketing, mergers and acquisitions, operating models, security, supply chain management, sustainability, technology consulting, technology innovation, and zero-based budgeting (ZBB). It specializes in the SAP business technology platform that designs digital products and experiences for enterprise customers, including custom portals and Web solutions and mobile applications. It provides clients with quantitative and qualitative risk management and compliance services. It specializes in advisory, management services and cybersecurity.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CMS Reports That Companies Choosing to Participate Include Accenture, Acentra Health, Conduent, GDIT, Deloitte, Gainwell, Maximus, and Curam by Merative
Participating Companies: Several companies, including Accenture, Acentra Health, and Deloitte, are voluntarily participating in a collaborative initiative.
Focus Areas: The initiative aims to address key health and wellness issues, with a focus on improving outcomes and enhancing community health.
Continue Reading
Palantir Stock Declines Amid Mixed Market Sentiment
- Market Underperformance: Despite a 0.6% rise in the tech sector, Palantir's stock fell 2.95%, reflecting mixed investor sentiment and indicating caution among market participants regarding the stock's outlook.
- Technical Analysis Pressure: Currently, Palantir's stock is trading 7.8% below its 20-day simple moving average and 9.6% below its 100-day average, suggesting short-term struggles, even as shares have increased by 100.40% over the past year.
- Earnings Report Outlook: Investors are looking forward to the earnings report on February 2, with an EPS estimate of $0.21 and revenue expected to reach $1.34 billion, indicating potential for significant revenue growth.
- Analyst Rating Changes: The stock carries a Hold rating with an average price target of $163.08, and recent upgrades from analysts reflect a more optimistic outlook for Palantir's future performance.
Continue Reading